Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Bone Marrow Transplant ; 30(3): 141-7, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12189531

ABSTRACT

Busulphan is used in conditioning regimens prior to SCT. A relationship between exposure to busulphan, expressed as an area under the plasma concentration time curve (AUC), and effect and/or adverse effects, such as veno-occlusive disease (VOD), was reported. Exhaustion of glutathione (GSH) contributes to VOD and modulation of intracellular levels of GSH influences bulsulphan-induced toxicity in hepatocytes. Thus, increase of GSH might serve as prophylaxis against VOD. However, it should not interfere with the myeloablative effects of busulphan. We investigated the relationship between exposure to busulphan, and its in vitro toxicity to CD34(+) hematopoietic progenitors from volunteers using clonogenic assays. Busulphan inhibited colony formation by CD34(+) cells in an AUC-dependent manner. Myeloid progenitors were more sensitive than erythroid progenitors, expressed as 100% inhibition of colony formation (68.7 +/- 7.5 microg.h/ml and 140.3 +/- 35.7, respectively). The observed exposure corresponds to the total AUC obtained in patients treated with busulphan (1 mg/kg/day) for 4 days. Secondly, we studied the effect of modulation of GSH cellular levels on busulphan-induced toxicity in vitro in CD34(+) cells from volunteers, and in vivo in bone marrow cells from Balb/c mice. The intracellular concentration of GSH was increased or decreased by treatment with N-acetylcysteine or buthionine sulfoximine, respectively. Neither in vitro nor in vivo treatment with GSH modulators affected the hematological toxicity of busulphan. Thus, N-acetylcysteine would not interfere with the myeloablative effect of busulphan and therefore it is a potential candidate for VOD prophylaxis during busulphan-based conditioning regimens.


Subject(s)
Antineoplastic Agents, Alkylating/pharmacology , Busulfan/pharmacology , Glutathione/physiology , Hematopoietic Stem Cells/drug effects , Acetylcysteine/pharmacology , Animals , Antigens, CD34 , Area Under Curve , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Buthionine Sulfoximine/pharmacology , Cell Death/drug effects , Colony-Forming Units Assay , Erythroid Precursor Cells/cytology , Erythroid Precursor Cells/drug effects , Glutathione/pharmacology , Hematopoietic Stem Cells/cytology , Humans , Mice , Mice, Inbred BALB C
2.
J Prosthet Dent ; 76(5): 530-4, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8933445

ABSTRACT

The purpose of this work was to study the effects of adding a mixture of gum arabic and calcium hydroxide to a type III stone and an improved die stone. The effect on the water/powder ratio, compressive and tensile strength, hardness, and setting expansion was determined. Data for mechanical properties were subjected to two-way analysis of variance, followed by the Bonferroni-Dunn procedure to determine any significance (1%) between pairs of means. For the type III material the additives had little effect on setting expansion, but the additives significantly improved surface hardness. The additives did not improve compressive or tensile strength for the type III materials. In contrast, the improved die stone's hardness was not enhanced by the additives, and in some instances a reduction in strength was observed. It was concluded that dental cast materials with superior surface properties can be produced by a simple change of formulation.


Subject(s)
Calcium Sulfate/chemistry , Models, Dental , Analysis of Variance , Calcium Hydroxide/chemistry , Compressive Strength , Gum Arabic/chemistry , Hardness , Materials Testing , Statistics, Nonparametric , Tensile Strength
SELECTION OF CITATIONS
SEARCH DETAIL